Current NDC auxiliary source row compounder:130

This page is keyed by dataset, FDA.report source record ID, and physical source row number. Empty values are shown rather than omitted.

Complete normalized row#

Record Source: ndc_compounder_zip
Product Ndc Raw: 71139-5355
Product Ndc: 71139-5355
Product Ndc Digits: 711395355
Product Type Name: HUMAN COMPOUNDED DRUG
Proprietary Name: Sugammadex
Proprietary Name Suffix: [empty]
Nonproprietary Name: Sugammadex
Dosage Form Name: INJECTION
Route Name: INTRAVENOUS
Marketing Category Name: OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
Labeler Name: IntegraDose Compounding Services, LLC
Establishment Name: IntegraDose Compounding Services, LLC
Establishment Fei: [empty]
Substance Name: SUGAMMADEX
Active Ingredients Info: 200 mg/2 mL
History Active Ingredients Raw: SUGAMMADEX
History Active Ingredients Info Raw: 200 mg/2 mL
History Dosage Raw: INJECTION
Dea Schedule: [empty]
Package Ndc Raw: 71139-5355-1
Package Ndc: 71139-5355-1
Package Ndc Digits: 7113953551
Package Ndc11: 71139535501
Package Description: 2 mL in 1 SYRINGE (71139-5355-1)
Reporting Period Raw: 2026-1
Reporting Period: 2026-1
Normalization Status: valid
Source Url: https://www.accessdata.fda.gov/cder/compounders_ndc_directory.zip
Source Archive: compounders_ndc_directory.zip
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Last Modified: Fri, 18 Sep 2026 15:17:23 GMT
Source Archive Sha256: 222f6800f79cb1a0fa79431b7226bd6b34899999dbf086af51004a96774ada98
Source Member Sha256: f8d9743e5616579a34d614887e86a53913efa0a63d3138d59d2f87cbb4d0cc17
Source Record Id: compounder:130
Source Row Number: 130
Source Row Hash: dca74fdd4c88215ea12df5f4ce51712598ac9710937a259bd65e2ad80c0af308
Import Run Id: 20261021T042902Z
Loaded At: 2026-10-21 04:33:26

Exact raw FDA source fields#

{
    "ROUTENAME": "INTRAVENOUS",
    "PRODUCTNDC": "71139-5355",
    "DEASCHEDULE": "",
    "LABELERNAME": "IntegraDose Compounding Services, LLC",
    "SUBSTANCENAME": "SUGAMMADEX",
    "DOSAGEFORMNAME": "INJECTION",
    "NDCPACKAGECODE": "71139-5355-1",
    "PRODUCTTYPENAME": "HUMAN COMPOUNDED DRUG",
    "PROPRIETARYNAME": "Sugammadex",
    "REPORTINGPERIOD": "2026-1",
    "NONPROPRIETARYNAME": "Sugammadex",
    "PACKAGEDESCRIPTION": "2 mL in 1 SYRINGE (71139-5355-1) ",
    "ACTIVEINGREDIENTSINFO": "200 mg/2 mL",
    "MARKETINGCATEGORYNAME": "OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)",
    "PROPRIETARYNAMESUFFIX": ""
}

Normalization notes#

[]

Current status projection#

Dataset: compounder
Record Source: ndc_compounder_zip
Source Record Id: compounder:130
Source Row Number: 130
Status Scope: package
Lookup Ndc: 71139-5355-1
Lookup Ndc Digits: 7113953551
Product Ndc: 71139-5355
Product Ndc Digits: 711395355
Package Ndc: 71139-5355-1
Package Ndc Digits: 7113953551
Package Ndc11: 71139535501
Product Id: [empty]
Status Code: COMPOUNDER
Status Label: Outsourcing facility compounded drug report
Reporting Period Raw: 2026-1
Reporting Period: 2026-1
Source Table: fda_ndc_aux_compounder
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Row Hash: dca74fdd4c88215ea12df5f4ce51712598ac9710937a259bd65e2ad80c0af308
Import Run Id: 20261021T042902Z
Loaded At: 2026-10-21 04:33:26